Dose Escalation of RMC-5552 Monotherapy in Relapsed/Refractory Solid Tumors
Revolution Medicines, Inc.
Revolution Medicines, Inc.
Blueprint Medicines Corporation
Blueprint Medicines Corporation
Blueprint Medicines Corporation
Revolution Medicines, Inc.
Syndax Pharmaceuticals
H. Lee Moffitt Cancer Center and Research Institute
VA Office of Research and Development
Valerio Therapeutics
Pharmacyclics LLC.